USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 149 filers reported holding USANA HEALTH SCIENCES INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $534,839 | +169.8% | 11,822 | +189.3% | 0.00% | +300.0% |
Q1 2024 | $198,207 | +2.7% | 4,087 | +24.1% | 0.00% | 0.0% |
Q3 2023 | $193,061 | +57.1% | 3,294 | +69.0% | 0.00% | 0.0% |
Q2 2023 | $122,865 | -77.2% | 1,949 | -77.3% | 0.00% | -66.7% |
Q1 2023 | $539,493 | -52.6% | 8,577 | -57.7% | 0.00% | -50.0% |
Q3 2022 | $1,137,000 | -14.3% | 20,291 | +10.6% | 0.01% | -25.0% |
Q2 2022 | $1,327,000 | -55.8% | 18,345 | -51.5% | 0.01% | -68.0% |
Q1 2022 | $3,003,000 | +43.3% | 37,797 | +82.5% | 0.02% | +25.0% |
Q4 2021 | $2,096,000 | +301.5% | 20,714 | +265.7% | 0.02% | +185.7% |
Q3 2021 | $522,000 | +64.7% | 5,664 | +83.0% | 0.01% | +75.0% |
Q2 2021 | $317,000 | -46.4% | 3,095 | -48.9% | 0.00% | -50.0% |
Q1 2021 | $591,000 | +43.8% | 6,055 | +13.6% | 0.01% | +33.3% |
Q4 2020 | $411,000 | -74.9% | 5,328 | -76.1% | 0.01% | -75.0% |
Q3 2020 | $1,639,000 | -61.0% | 22,256 | -61.1% | 0.02% | -67.1% |
Q2 2020 | $4,201,000 | +190.3% | 57,216 | +128.4% | 0.07% | +87.2% |
Q1 2020 | $1,447,000 | +395.5% | 25,049 | +574.8% | 0.04% | +680.0% |
Q4 2019 | $292,000 | -70.0% | 3,712 | -73.9% | 0.01% | -73.7% |
Q3 2019 | $974,000 | -37.7% | 14,246 | -27.7% | 0.02% | -34.5% |
Q2 2019 | $1,564,000 | -43.8% | 19,692 | -40.7% | 0.03% | -67.8% |
Q1 2019 | $2,784,000 | +850.2% | 33,195 | +1232.1% | 0.09% | +542.9% |
Q4 2018 | $293,000 | -65.1% | 2,492 | -64.2% | 0.01% | -69.6% |
Q3 2018 | $839,000 | -35.6% | 6,960 | -38.4% | 0.05% | -29.2% |
Q2 2018 | $1,303,000 | -46.2% | 11,302 | -59.9% | 0.06% | -54.2% |
Q1 2018 | $2,423,000 | +1182.0% | 28,209 | +763.2% | 0.14% | +1190.9% |
Q3 2017 | $189,000 | -18.9% | 3,268 | -14.0% | 0.01% | -42.1% |
Q4 2016 | $233,000 | -23.6% | 3,800 | +38.8% | 0.02% | +5.6% |
Q2 2016 | $305,000 | -24.1% | 2,738 | -13.0% | 0.02% | -25.0% |
Q4 2015 | $402,000 | -17.8% | 3,147 | -13.7% | 0.02% | -4.0% |
Q3 2015 | $489,000 | +72.2% | 3,648 | +31.6% | 0.02% | +66.7% |
Q4 2014 | $284,000 | – | 2,772 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Technologies Management, LLC | 42,276 | $3,195,000 | 2.92% |
Capital Impact Advisors, LLC | 21,373 | $1,615,000 | 1.30% |
Matarin Capital Management, LLC | 18,266 | $1,381,000 | 0.85% |
ALGERT GLOBAL LLC | 25,440 | $1,923,000 | 0.51% |
Phocas Financial Corp. | 125,970 | $10,231,000 | 0.48% |
Camarda Financial Advisors, LLC | 6,918 | $523,000 | 0.43% |
Wolf Group Capital Advisors | 6,645 | $502,000 | 0.40% |
Spark Investment Management LLC | 27,100 | $2,048,000 | 0.36% |
CLARK ESTATES INC/NY | 32,059 | $2,423,000 | 0.34% |
JAMES INVESTMENT RESEARCH, INC. | 118,515 | $8,957,000 | 0.28% |